Jen Morawiak

Jen Morawiak has extensive experience in the clinical research field. Jen is currently working as the Director of Clinical Trials at Tango Therapeutics since September 2022. Prior to that, they worked at Alexion Pharmaceuticals as the Associate Director of Clinical Project Lead from June 2019 to November 2020, and then as the Senior Manager of Clinical Project Lead from November 2020 to September 2022. Before Alexion Pharmaceuticals, they held the position of CTL at Novartis from August 2013 to June 2019. Jen also has experience at AVEO Oncology as the Lead Clinical Research Associate from June 2011 to August 2013, and as the Senior Clinical Research Associate from June 2011 to February 2013. Additionally, they worked at Genzyme Corporation as a Clinical Research Associate from August 2005 to May 2011, where they supported various clinical projects and helped meet post-market approval requirements. Their earlier work experience includes roles as a Research Associate at the Broad Institute from May 2004 to August 2005, and at Millennium Pharmaceuticals from 2000 to 2004, where they were responsible for cloning cDNA sequences and compiling a DNA library.

Jen Morawiak obtained their Master's degree in MA from Boston University School of Medicine from 2005 to 2010. Prior to that, they attended Ithaca College from 1996 to 2000.